Stock Scorecard

Stock Summary for (CLVS) - $0.08 as of 9/1/2023 9:42:27 PM EST

Total Score

9 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CLVS

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CLVS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CLVS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for CLVS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Financial Details for CLVS

Company Overview
Ticker CLVS
Company Name
Country N/A
Description Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and marketing anticancer agents in the United States, the European Union, and internationally. The company is headquartered in Boulder, Colorado.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2022
Next Earnings Date 11/7/2023

Stock Price History
Last Day Price 0.08
Last Day Price Updated 9/1/2023 9:42:27 PM EST
Last Day Volume 0
Average Daily Volume 9,046,214
52-Week High 3.25
52-Week Low 0.04
Last Price to 52 Week Low 100.00 %

Valuation Measures
Trailing PE N/A
Industry PE 43.96
Sector PE 47.89
5-Year Average PE -1.42
Free Cash Flow Ratio 0.20
Industry Free Cash Flow Ratio 12.58
Sector Free Cash Flow Ratio 31.90
Current Ratio Most Recent Quarter 0.14
Total Cash Per Share 0.40
Book Value Per Share Most Recent Quarter -2.89
Price to Book Ratio 0.00
Industry Price to Book Ratio 4.72
Sector Price to Book Ratio 21.80
Price to Sales Ratio Twelve Trailing Months 0.11
Industry Price to Sales Ratio Twelve Trailing Months 5.61
Sector Price to Sales Ratio Twelve Trailing Months 3.72

Share Statistics
Total Shares Outstanding 144,955,000
Market Capitalization 11,596,400
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00 %
5-Year Dividend Payments Count 0
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00 %
Annual Earnings Growth 28.35 %
Reported EPS 12 Trailing Months 0.00
Reported EPS Past Year -1.33
Reported EPS Prior Year -2.29
Net Income Twelve Trailing Months -251,904,000
Net Income Past Year -264,524,000
Net Income Prior Year -369,212,000
Quarterly Revenue Growth YOY -19.10 %
5-Year Revenue Growth 25.34 %

Balance Sheet
Total Cash Most Recent Quarter 58,320,000
Total Cash Past Year 143,428,000
Total Cash Prior Year 240,229,000
Net Cash Position Most Recent Quarter -384,962,000
Net Cash Position Past Year -728,838,000
Long Term Debt Past Year 872,266,000
Long Term Debt Prior Year 497,584,000
Total Debt Most Recent Quarter 443,282,000
Equity to Debt Ratio Past Year 0.00
Equity to Debt Ratio Most Recent Quarter 0.00
Total Stockholder Equity Past Year 129,000
Total Stockholder Equity Prior Year 104,000
Total Stockholder Equity Most Recent Quarter 145,000

Options
Put/Call Ratio 0.30
Has Options False
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.22
RSI 0.00
50-Day SMA 0.00
200-Day SMA 0.00

System
Modified 9/27/2023 8:43:55 PM EST